Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance

[1]  M. Palka-Santini,et al.  Cost-Effectiveness Modeling Of Antimicrobial Dressings For Preventing Catheter-Related Bloodstream Infection: Homogeneous Verse Non-Homogeneous Markov Approaches. , 2014, Value in Health.

[2]  M. Palka-Santini,et al.  Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In France: A Comparison Of Two Modeling Approaches: Decision-Tree Versus Non-Homogeneous Markov Model. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  M. Wilcox,et al.  epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England , 2007, Journal of Hospital Infection.

[4]  S. Ruckly,et al.  Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units , 2013 .

[5]  Kristine M. Thompson,et al.  Intravascular Catheter-Related Bloodstream Infection , 2013, The Neurohospitalist.

[6]  Geoff Bellingan,et al.  ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England , 2012, BMJ quality & safety.

[7]  B. Souweine,et al.  Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. , 2012, American journal of respiratory and critical care medicine.

[8]  M. Campbell,et al.  NICE Medical Technologies Guidance , 2012, Applied Health Economics and Health Policy.

[9]  M. Campbell,et al.  NICE Medical Technologies Guidance: a novel and rigorous methodology to address a new health technology assessment challenge. , 2012, Applied health economics and health policy.

[10]  M. Bashir,et al.  Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. , 2012, American journal of infection control.

[11]  J. Timsit,et al.  Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study* , 2012, Critical care medicine.

[12]  M. Rupnow,et al.  Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States. , 2011, American journal of infection control.

[13]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[14]  N. Moureau,et al.  Evaluation of the clinical performance of a chlorhexidine gluconate antimicrobial transparent dressing , 2009 .

[15]  J. Zarocostas.  Non-communicable diseases must have greater priority, says WHO , 2009, BMJ : British Medical Journal.

[16]  R. Curtis.  Catheter-Related Bloodstream Infection in the Intensive Care Unit , 2009 .

[17]  C. Coopersmith,et al.  Catheter-related bloodstream infection. , 2009, The Surgical clinics of North America.

[18]  J. Timsit,et al.  Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. , 2009, JAMA.

[19]  K. Maryniak.  Clinical Performance and Nursing Satisfaction of a Transparent Chlorhexidine Gluconate IV Securement Dressing with Peripherally Inserted Central Catheters , 2009 .

[20]  T. Walley,et al.  The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. , 2008, Health technology assessment.

[21]  J. Heilman,et al.  Clinical Performance of a New Transparent Chlorhexidine Gluconate Central Venous Catheter Dressing , 2008 .

[22]  J. Pyrek,et al.  A Controlled Randomized Prospective Comparative Pilot Study to Evaluate the Ease of Use of a Transparent Chlorhexidine Gluconate Gel Dressing Versus A Chlorhexidine Gluconate Disk in Healthy Volunteers , 2008 .

[23]  K. Ho,et al.  Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. , 2006, The Journal of antimicrobial chemotherapy.

[24]  J. Fuhr,et al.  Cost–Benefit Analysis of Chlorhexidine Gluconate Dressing in the Prevention of Catheter-Related Bloodstream Infections , 2004, Infection Control & Hospital Epidemiology.

[25]  S. Saint,et al.  The Clinical and Economic Consequences of Nosocomial Central Venous Catheter-Related Infection: Are Antimicrobial Catheters Useful? , 2000, Infection Control & Hospital Epidemiology.

[26]  S. Saint,et al.  Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. , 1999, JAMA.

[27]  B. Roberts,et al.  Biopatch--a new concept in antimicrobial dressings for invasive devices. , 1998, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[28]  P. Cuddy,et al.  No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. , 1996, Archives of surgery.

[29]  Graham E. Smith,et al.  Evaluation of a New CHG Gel Pad Dressing for Catheter Care , 2022 .